Article ; Online: Patient-Derived Antibody Data Yields Development of Broadly Cross-Protective Monoclonal Antibody against ST258 Carbapenem-Resistant
2022 Volume 10, Issue 4, Page(s) e0176022
Abstract: The most pressing challenge for the development of anti-capsular antibodies is maximizing coverage against the heterogenous capsular polysaccharide (CPS) of carbapenem-resistant Klebsiella pneumoniae (CR- ...
Abstract | The most pressing challenge for the development of anti-capsular antibodies is maximizing coverage against the heterogenous capsular polysaccharide (CPS) of carbapenem-resistant Klebsiella pneumoniae (CR- |
---|---|
MeSH term(s) | Animals ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Antibodies, Monoclonal/therapeutic use ; Carbapenems/pharmacology ; Carbapenems/therapeutic use ; Klebsiella Infections/drug therapy ; Klebsiella Infections/prevention & control ; Klebsiella pneumoniae ; Macrophages ; Mice |
Chemical Substances | Anti-Bacterial Agents ; Antibodies, Monoclonal ; Carbapenems |
Language | English |
Publishing date | 2022-07-11 |
Publishing country | United States |
Document type | Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S. |
ZDB-ID | 2807133-5 |
ISSN | 2165-0497 ; 2165-0497 |
ISSN (online) | 2165-0497 |
ISSN | 2165-0497 |
DOI | 10.1128/spectrum.01760-22 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.